Entafiga

Entafiga is a medication used to treat high cholesterol levels, specifically low-density lipoprotein (LDL) cholesterol, in adults. It belongs to a class of drugs known as proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors. PCSK9 is a protein that plays a role in the regulation of LDL cholesterol levels in the body. By inhibiting PCSK9, entafiga helps to reduce the amount of LDL cholesterol in the blood.

Entafiga is available in tablet form and is typically taken once daily, with or without food. The recommended starting dose is 60 milligrams, which can be increased to 120 milligrams if necessary. The medication is not recommended for use in patients with a history of liver disease or those who are allergic to any of its components.

Common side effects of entafiga may include muscle pain, back pain, and injection site reactions. Serious side effects are rare but can include muscle injury, liver problems, and increased risk of heart attack or stroke. It is important for patients to discuss any side effects or concerns with their healthcare provider.

Entafiga should be used in combination with a statin to achieve the best cholesterol-lowering effect. Patients should undergo regular monitoring of their cholesterol levels and liver function while taking entafiga. The medication should be discontinued if any serious side effects occur.